Also sold as: Foradil, Formatris, Foracort (with budesonide), Symbicort (with budesonide)
Pregnancy
Cat C
Lactation
Caution
Schedule
H
Forms
DPI capsule 12 mcg (Aerolizer) +2
COPD / Asthma (maintenance)
12 mcg inhaled BD (Aerolizer DPI)
Ongoing
Combination (Foracort 200/6)
1-2 puffs BD (ICS/LABA fixed combination)
Preferred over monotherapy for asthma
LABA monotherapy in asthma is CONTRAINDICATED in children — must always combine with ICS
| CrCl / eGFR | Dose Adjustment |
|---|---|
| Any | No adjustment; inhaled route minimal systemic absorption |
No significant adjustment required
Pregnancy: Category C
Inhaled LABAs generally considered safe; prefer salbutamol for acute relief. Formoterol may be continued in well-controlled asthma — uncontrolled asthma is greater risk.
Lactation: Caution
Unknown in breast milk; inhaled route systemic exposure minimal — likely safe.
| Interacting Drug | Effect | Severity |
|---|---|---|
| MAO inhibitors / Tricyclic antidepressants | Increased cardiovascular effects — avoid combination | Major |
| Non-selective beta-blockers (propranolol) | Antagonism of bronchodilator effect; potential severe bronchospasm | Major |
| QT-prolonging drugs | Additive QT prolongation | Moderate |
| Loop diuretics / Thiazides | Hypokalaemia — monitor K+ especially in severe asthma | Moderate |
DoctorScribe — AI Medical Scribe
"Foradil as per dose, BD for 5 days." DoctorScribe writes the full prescription with brand, strength, frequency, and route — auto-applies pediatric weight-based dosing and renal adjustments. Try the live demo.
Common
Serious / Discontinue If
| Brand | Manufacturer | Price (approx) |
|---|---|---|
| Foradil 12 mcg Aerolizer | Novartis | 30 cap ₹485 |
| Foracort 200/6 Inhaler | Cipla | 120 puffs ₹395 |
| Formatris 12 mcg | Cipla | 30 cap ₹325 |
EasyClinic auto-flags Foradil interactions, renal cutoffs, and pregnancy warnings the moment you write the prescription. Built-in safety net for every Indian doctor.
Clinically reviewed by: Dr. Kavitha Rao, MD (Pulmonology), Consultant
Last reviewed: 2026-04-01